These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21573834)

  • 21. Diffuse type advanced gastric cancer showing dismal prognosis is characterized by deeper invasion and emerging peritoneal cancer cell: the latest comparative study to intestinal advanced gastric cancer.
    Yamashita K; Sakuramoto S; Katada N; Futawatari N; Moriya H; Hirai K; Kikuchi S; Watanabe M
    Hepatogastroenterology; 2009; 56(89):276-81. PubMed ID: 19453074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Related factors and prognosis of hepatic metastasis and peritoneal dissemination in gastric cancer].
    Wang Z; Zhan WH; He YL; Cai SR; Peng JS; Chen CQ; Ma JP; Zheng ZQ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jul; 9(4):287-90. PubMed ID: 16886104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peritoneal carcinomatosis and lymph node metastasis are prognostic indicators in patients with Borrmann type IV gastric carcinoma.
    Chen CY; Wu CW; Lo SS; Hsieh MC; Lui WY; Shen KH
    Hepatogastroenterology; 2002; 49(45):874-7. PubMed ID: 12064011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnitude of serosal changes predicts peritoneal recurrence of gastric cancer.
    Bando E; Kawamura T; Kinoshita K; Takahashi S; Maeda A; Osada S; Tsubosa Y; Yamaguchi S; Uesaka K; Yonemura Y
    J Am Coll Surg; 2003 Aug; 197(2):212-22. PubMed ID: 12892799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters.
    Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
    J Surg Oncol; 2007 Feb; 95(2):123-8. PubMed ID: 17262742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. D2-lymphadenectomy improves the survival of patients with peritoneal cytology-positive gastric cancer.
    Inada T; Ogata Y; Kubota T; Ishihara M; Tomikawa M; Ando J; Ozawa I; Hishinuma S; Shimizu H; Kotake K
    Anticancer Res; 2002; 22(1A):291-4. PubMed ID: 12017305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of HLA class I heavy chain expression in patients with gastric cancer.
    Ueda Y; Ishikawa K; Shiraishi N; Yokoyama S; Kitano S
    J Surg Oncol; 2008 Apr; 97(5):451-5. PubMed ID: 18247377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined epithelial-mesenchymal transition with cancer stem cell-like marker as predictors of recurrence after radical resection for gastric cancer.
    Xu GF; Zhang WJ; Sun Q; Xu X; Zou X; Guan W
    World J Surg Oncol; 2014 Dec; 12():368. PubMed ID: 25441488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test.
    Yamashita K; Ushiku H; Katada N; Hosoda K; Moriya H; Mieno H; Kikuchi S; Hoshi K; Watanabe M
    Eur J Surg Oncol; 2015 Oct; 41(10):1324-32. PubMed ID: 26251341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The utility of pre-operative peritoneal lavage examination in serosa-invading gastric cancer patients.
    Makino T; Fujiwara Y; Takiguchi S; Miyata H; Yamasaki M; Nakajima K; Nishida T; Mori M; Doki Y
    Surgery; 2010 Jul; 148(1):96-102. PubMed ID: 20096433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of osteopontin expression in human gastric carcinoma.
    Higashiyama M; Ito T; Tanaka E; Shimada Y
    Ann Surg Oncol; 2007 Dec; 14(12):3419-27. PubMed ID: 17896150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of T antigen expression in patients with gastric carcinoma.
    Chung YS; Yamashita Y; Kato Y; Nakata B; Sawada T; Sowa M
    Cancer; 1996 May; 77(9):1768-73. PubMed ID: 8646672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is extended lymphadenectomy valuable in palliatively gastrectomized patients with gastric cancer and simultaneous peritoneal metastasis?
    Kikuchi S; Arai Y; Kobayashi N; Tsukamoto H; Shimao H; Sakakibara Y; Hiki Y; Kakita A
    Hepatogastroenterology; 2000; 47(32):563-6. PubMed ID: 10791239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical outcome of node-positive early gastric cancer with particular reference to nodal status.
    Kikuchi S; Sato M; Katada N; Sakuramoto S; Kobayashi N; Shimao H; Sakakibara Y; Kakita A
    Anticancer Res; 2000; 20(5C):3695-700. PubMed ID: 11268441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of peritoneal lavage smears and gastric wall brushing smears in gastric cancer surgery].
    Shirakawa T; Onda M; Tokunaga A; Fujita I; Teramoto T; Takita M; Oguri T; Okuda T; Kiyama T; Yoshiyuki T; Kato S; Miyashita M; Naito Z; Matsukura N; Yamashita K; Asano G
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1472-5. PubMed ID: 8854783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Examination of cancer cells exposed to gastric serosa by serosal stamp cytology plus RT-PCR is useful for the identification of gastric cancer patients at high risk of peritoneal recurrence.
    Miki Y; Yashiro M; Ando K; Okuno T; Kitayama K; Masuda G; Tamura T; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Osawa M; Hirakawa K; Ohira M
    Surg Oncol; 2017 Dec; 26(4):352-358. PubMed ID: 29113652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of RegIV in peritoneal dissemination of gastric cancer and its potential as A novel marker for the detection of peritoneal micrometastasis.
    Miyagawa K; Sakakura C; Nakashima S; Yoshikawa T; Fukuda K; Kin S; Nakase Y; Shimomura K; Oue N; Yasui W; Hayasizaki H; Okazaki Y; Yamagishi H; Hagiwara A; Otsuji E
    Anticancer Res; 2008; 28(2B):1169-79. PubMed ID: 18505053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of ERas oncogene in gastric carcinoma.
    Kaizaki R; Yashiro M; Shinto O; Yasuda K; Matsuzaki T; Sawada T; Hirakawa K
    Anticancer Res; 2009 Jun; 29(6):2189-93. PubMed ID: 19528480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative detection of carcinoembryonic antigen messenger RNA in the peritoneal cavity of gastric cancer patients by real-time quantitative reverse transcription polymerase chain reaction.
    Ueno H; Yoshida K; Hirai T; Kono F; Kambe M; Toge T
    Anticancer Res; 2003; 23(2C):1701-8. PubMed ID: 12820444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear expression of chemokine receptor CXCR4 indicates poorer prognosis in gastric cancer.
    Masuda T; Nakashima Y; Ando K; Yoshinaga K; Saeki H; Oki E; Morita M; Oda Y; Maehara Y
    Anticancer Res; 2014 Nov; 34(11):6397-403. PubMed ID: 25368239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.